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EXPERIMENTAL STUDY
Puerarin reduces apoptosis in rat hippocampal neurons cultured in
high glucose medium by modulating the p38 mitogen activated
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Abstract
OBJECTIVE: To investigate the neuroprotective ef-
fect of puerarin on rat hippocampal neurons cul-
tured in high glucose medium, and to examine the
role of the p38 mitogen activated protein kinase
(p38 MAPK) and c-Jun N-terminal kinase (JNK) sig-
naling pathways in this effect.
METHODS: Primary cultures of hippocampal neu-
rons were prepared from newborn Sprague Dawley
rats. Neuron-specific enolase immunocytochemis-
try was used to identify neurons. The neurons were
cultured with normal medium (control group) or
with high-glucose medium (high-glucose group),
and puerarin (puerarin group), a p38 MAPK inhibi-
tor (SB239063; p38 MAPK inhibitor group) or a JNK
inhibitor (SP600125; JNK inhibitor group) were add-
ed. After 72 h of treatment, terminal deoxynucleo-
tidyl transferase-mediated dUTP nick end labeling
assay was performed to detect apoptosis, and west-
ern blotting was used to assess protein levels of
p-p38, p38, p-JNK and JNK.
RESULTS: In the high-glucose group, the neuronal
apoptosis rate and the p-p38/p38 and p-JNK/JNK
ratios were higher than in the control group. The
p38 MAPK and JNK inhibitors prevented this in-
crease in the apoptosis rate. The apoptosis rates in
the puerarin group, the p38 MAPK inhibitor group
and the JNK inhibitor group were significantly de-
creased compared with the high-glucose group.
Moreover, protein levels of p-p38 and p-JNK were
significantly reduced, and the p-p38/p38 and
p-JNK/JNK ratios were decreased in the puerarin
group compared with the high-glucose group. In
addition, compared with the high-glucose group,
p-p38 levels and the p-p38/p38 ratio were reduced
in the p38 MAPK inhibitor group, and p-JNK levels
and the p-JNK/JNK ratio were decreased in the JNK
inhibitor group.
CONCLUSION: Puerarin attenuates neuronal apop-
tosis induced by high glucose by reducing the
phosphorylation of p38 and JNK.
© 2016 JTCM.
Key words: Glucose; Hippocampus; Puerarin; p38
mitogen-activated protein kinases; JNK mitogen-ac-
tivated protein kinases
INTRODUCTION
The incidence rate of diabetes increases every year in
China, and it is a common, chronic metabolic disease
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with an array of potentially serious complications such
as diabetic retinitis, diabetic nephropathy and diabetic
peripheral neuropathy.1-5 As the average lifespan increas-
es and living standards improve,6 the central nervous
system damage produced by diabetes has been attract-
ing increasing attention.7 The hippocampus is a critical
brain region related to learning and memory in the
mammalian brain, and it is more likely to be influ-
enced by blood glucose levels.8 Gegen (Radix Puerariae
Lobatae) [a herb in Traditional Chinese Medicine
(TCM) ] is one of the most common medicines for
treating diabetes. This medicine enters the meridians
of the spleen and stomach, expels pathogenic factors
from muscles to remove heat, generates fluid, and re-
lieves thirst, according to the concepts of TCM. Puera-
rin is the main active ingredient in Gegen (Radix Puer-
ariae Lobatae). In the present study, we investigated the
effects of puerarin on primary rat hippocampal neu-
rons cultured in high-glucose medium, and we exam-
ined the underlying molecular mechanisms.
MATERIALS ANDMETHODS
Animals
A total of 24 male and 24 female 1-day-old specific
pathogen-free Sprague Dawley rats, weighing 4-6 g,
were supplied by Beijing HFK Bioscience Co., Ltd.
[Beijing, China. License number: SCXK (Jing)
2009-0004]. The study was approved by the Animal
Welfare Ethics Committee of Peking Union Medical
College Hospital.
Main reagents and instruments
The p38 MAPK inhibitor SB239063 and the JNK in-
hibitor SP600125 were purchased from Sigma-Aldrich
(purity ≥ 98% ; St. Louis, MO, USA). Puerarin was
purchased from the Chinese Food and Drug Inspec-
tion Institute (purity 95.5%; Beijing, China). Sodium
pyruvate, glutamine, sodium deoxycholate, dimethyl
sulfoxide (DMSO), sodium dodecyl sulfate (SDS), Tris
base and poly-L-lysine were purchased from Sigma-Al-
drich. p-p38, p-JNK and JNK antibodies were pur-
chased from Cell Signaling Technology (Danvers, MA,
USA). p38 antibody was purchased from Abcam (Cam-
bridge, UK). Nerve growth factor (NGF) was pur-
chased from Millipore (Cambridge, MA, USA). Neu-
ron-specific enolase (NSE) antibody was purchased
from Bioworld (St. Louis Park, MN, USA). HEPES
was purchased from Amresco (Solon, OH, USA). In Si-
tu Cell Death Detection Kit was purchased from
Roche (Basel, Switzerland). Triton X-100 was pur-
chased from Nacalai Tesque (Kyoto, Japan). DNase I
was purchased from Takara (Shiga-ken, Japan). Phos-
phate buffered saline (PBS), D-Hank's, DMEM-high
glucose, fetal bovine serum (FBS) and 0.25% trypsin/
0.03% ethylenediaminetetraacetic acid (EDTA) were
purchased from Peking Union Medical College Hospi-
tal (Beijing, China). Glucose, NaCl, KCl, Na2HPO4,
KH2PO4 and NaHCO3 were purchased from the Chi-
nese Food and Drug Inspection Institute (Beijing, Chi-
na). Hematoxylin and paraformaldehyde were pur-
chased from Beijing Chemical Reagent Co., Ltd. (Bei-
jing, China). Secondary antibody was purchased from
North China Pharmaceutical (Hebei, China). Lympho-
cyte Separation Medium was purchased from Haoyang
(Tianjin, China). Diaminobenzidine Color Developing
Reagent Kit was purchased from Beijing Jinqiao Com-
pany (Beijing, China). Bicinchoninic acid protein con-
centration assay kit was purchased from Beyotime Bio-
technology (Jiangsu, China). TCS SP2SE laser scan-
ning confocal microscope was purchased from Leica
Camera AG, (Wetzlar, Germany). CKX31SF inverted
phase contrast microscope and IX71-A12FL inverted
phase contrast fluorescence microscope were purchased
from Olympus (Tokyo, Japan).
Preparation of stock solutions
For the puerarin stock solution, 5 mg of puerarin was
dissolved in 30 ml DMEM complete medium, passed
through a 0.22 μm filter, adjusted to a final concentra-
tion of 400 μmol/L, and stored at －20 ℃ . The solu-
tion was diluted to the appropriate concentration with
DMEM complete medium before use.9
For the SB239063 stock solution, 5 mg SB239063 was
dissolved in 500 μL of DMSO, and 50 μL of this stock
was added to 33.931 mL of DMEM complete medi-
um, passed through a 0.22 μm filter, diluted to a final
concentration of 40 μmol/L, and stored at － 20 ℃ .
This solution was diluted with DMEM complete medi-
um to a concentration of 10 μmol/L before use.10
For the SP600125 stock solution, 5 mg SP600125 was
dissolved in 2.5 mL of DMSO, and 25 μL of this stock
was added to 56.736 ml of DMEM complete medium,
passed through a 0.22 μm filter, diluted to a final con-
centration of 40 μmol/L, and stored at －20 ℃ . This
solution was diluted with DMEM complete medium
to a concentration of 10 μmol/L before use.11
Preparation of DMEM complete medium
DMEM was supplemented with 10% FBS (final con-
centration), glutamine (2 mmol/L), sodium pyruvate
(1 mmol/L), HEPES (20 mmol/L), 100 U/mL penicil-
lin and 100μg/mL streptomycin, andNGF (10ng/mL).
Experimental groups
After 2 days of culture, the original DMEM complete
medium was replaced with treatment medium. The
control group was treated with DMEM complete medi-
um. In the high-glucose group, glucose was added to
the DMEM complete medium to a final concentration
of 50 mM. In the puerarin group, the high-glucose me-
dium was supplemented with 25 μmol/L puerarin. In
the p38 MAPK inhibitor group, the high-glucose medi-
um was supplemented with 10 μmol/L SB239063. In
the JNK inhibitor group, the high-glucose medium
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was supplemented with 10 μmol/L SP600125. All me-
dia were passed through a 0.22 μm filter and trans-
ferred to 96-well culture plates.
Isolation, purification, culturing, and identification
of hippocampal neurons
The hippocampi were removed from 1-day-old
Sprague Dawley rats, and the tissue was digested
with trypsin. Neurons were then purified by density
gradient centrifugation, and identified by NSE immu-
nofluorescence. The neurons were observed and pho-
tographed under a confocal laser scanning micro-
scope, using 10 randomly selected fields of view. The
number of positive cells and the total number of
cells in each field were counted, and the cell purity
was calculated.12
Apoptoic cells detection by terminal deoxynucleotidyl
transferasemediated dUTO nick end labeling
(TUNEL)
Cells were seeded at 5 × 105 cells per well in 6-well cul-
ture plates containing a coverslip, and 3 days later, the
medium was replaced with the appropriate treatment
medium. Then, 72 h after culturing, the cells were
rinsed and fixed with 4% paraformaldehyde at room
temperature for 1 h. Cells were then permeabilized
with 0.1% Triton X-100 for 6 min. For the positive
control group, 50 μL of DNase I was added into the
cells and incubated at room temperature for 10 min.
Then, 50 μL of the TUNEL reaction mix was added,
and the cells were incubated in a dark humidified
chamber at 37 ℃ for 60 min. For the negative control
group, only the reaction mix was added. Under the flu-
orescence microscope (excitation wave length of 530
nm), positive cells appeared green. Then, 50 μL of per-
oxidase transition agent was added, and the cells were
incubated in a dark humidified chamber at 37 ℃ for
30 min. Thereafter, 50 μL of the diaminobenzidine
(DAB) solution was added into the cells, and the reac-
tion was terminated when specific yellow granules ap-
peared in the nuclei under the microscope. After
mounting, the cells were observed under the light mi-
croscope.
Western blotting for p-p38, p38, p-JNK and JNK
Cooled radio immunoprecipitation (RIPA) lysate was
added to the cells, incubated on ice, and then centri-
fuged to obtain the supernatant. The protein concen-
tration of each group was calculated in accordance
with the Bicinchoninic acid (BCA) protein concentra-
tion kit. Proteins were separated by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE)
and blotted onto membranes. The membranes were
then incubated with primary antibody (rabbit an-
ti-mouse p-p38, p38, p-JNK or JNK polyclonal anti-
body) and secondary antibody (goat anti-rabbit IgG).
The membranes were rinsed and photographed, and
the images were then analyzed with Lab Works 4.6 im-
age analysis software (The Lab Works, Winnipeg,
Canada). Gray scale scanning values of the target pro-
teins and the reference proteins in each group were
recorded.12
Statistical analyses
Data are expressed as mean ± standard deviation ( xˉ ±
s). All analyses were performed with SPSS 17.0 (SPSS
Inc., Chicago, IL, USA). Before analysis, the normal
distribution of the data was confirmed with a
one-sample Kolmogorov-Smirnov Z test, and in-
ter-group comparisons of independent, normally dis-
tributed samples were performed using one-way anal-
ysis of variance. The statistical significance level was
set at P < 0.05.
RESULTS
Morphology, identification, and purity of
hippocampal neurons
Newly seeded hippocampal neurons were small and
round, suspended in medium, uniformly distributed,
and with a good refractive index under the inverted
microscope. After 1 day in culture, most cells had
adhered. After 3 days, neurons, mainly consisting of
multipolar cells, increased in size and were plump
with halos. Most neurons were spindle or coni-
cal-shaped, and the rest were polygonal, with a great-
er number of (and longer) protrusions, connecting
the neurons together in a sparse network. The cells
cultured for 3 days were immunostained for NSE.
All nuclei were stained blue, and cells with their cy-
toplasm and protrusions stained green were NSE-pos-
itive cells, namely neurons (Figure 1). Under the
confocal laser scanning microscope, 10 fields of view
were selected at random for observation. The neuro-
nal purity, defined as the proportion of NSE-positive
cells to the total number of cells, was 95.4% ±
2.3%.
Effects of puerarin, p38 MAPK inhibitor and JNK
inhibitor on the apoptosis of hippocampal neurons
treated with high glucose, as detected by TUNEL
Using the TUNEL assay, the nuclei of apoptotic cells
were stained yellow, while surviving cells were stained
blue by hematoxylin. Neurons in the control group
were plump with extended axons, and their apoptosis
rate was lower (control group apoptosis rate: 10.16% ±
1.83%). Neurons in the high-glucose group appeared
shrunk with shorter axons, and the apoptosis rate was
significantly higher (high-glucose group apoptosis rate:
28.13% ± 5.28% ). The apoptosis rates in the other
groups were intermediate (puerarin group apoptosis
rate: 19.80% ± 3.52% ; p38 MAPK inhibitor group
apoptosis rate: 18.18% ± 3.97%; JNK inhibitor apop-
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tosis rate: 17.41% ± 1.88%). Compared with the con-
trol group, the neuronal apoptosis rate in the high-glu-
cose group was higher (P < 0.01). Compared with the
high-glucose group, the neuronal apoptosis rates in the
puerarin group, the p38 MAPK inhibitor group and
the JNK inhibitor group were lower (puerarin group:
P < 0.05; others P < 0.01). In comparison, no signifi-
cant difference in apoptosis rates (P > 0.05) was found
among the puerarin group, the p38 MAPK inhibitor
group and the JNK inhibitor group (Figure 2).
Western blotting for p-p38, p38, p-JNK and JNK in
hippocampal neurons
There was no significant difference in expression of the
reference protein, β-actin, among the various groups.
Compared with the control group, protein levels of
p-p38, p38, p-JNK and JNK in the high-glucose
group were increased, as well as the p-p38/p38 and
p-JNK/JNK ratios. Compared with the high-glucose
group, levels of p-p38 and p-JNK in the puerarin
group were significantly reduced, and the p-p38/p38
and p-JNK/JNK ratios were lower. The levels of p-p38
(and the p-p38/p38 ratio) in the p38 MAPK inhibitor
group were decreased, as were the levels of p-JNK (and
the p-JNK/JNK ratio) in the JNK inhibitor group.
Compared with the p38 MAPK inhibitor group, the
upregulation of p-p38 and the increase in the p-p38/
p38 ratio (P < 0.01) were blocked in the puerarin
CBA
ED
Figure 2 Apoptosis of neuron in each group was assessed using TUNEL (×200)
A: control group: cells were cultured with DMEM complete medium for 72 h. B: high-glucose group: cells were cultured with glu-
cose (50 mmol/L) for 72 h. C: puerarin group: cells were cultured with puerarin (25 μmol/L) for 72 h. D: p38 MAPK inhibitor group:
cells were cultured with SB239063 (10 μmol/L) for 72 h. E: c- JNK inhibitor group: cells were cultured with SP600125 (10 μmol/L)
for 72 h. DMEM: dulbecco's modified eagle medium; TUNEL: terminal deoxynucleotidyl transferasemediated dUTO nick end label-
ing; MAPK: mitogen activated protein kinase; JNK: c-Jun N-terminal kinase.
A B C
D E F
Figure 1 Purity of hippocampal neurons cultured in vitro as determined by immunofluorescent staining (A-C, ×200; D-E, ×600)
A, D: all the cells were stained with DAPI. B, E: neurons labeled by immunofluorescence staining for NSE. C, F: double-labeling. DA-
PI: 4', 6-Diamidino-2-Phenylindole; NSE: neuron-specific enolase.
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group. Compared with the JNK inhibitor group, the
upregulation of p-JNK (and the increase in the p-JNK/
JNK ratio) (P < 0.01) were also prevented in the puera-
rin group. Gray scale scanning values for the reference
protein β-actin and the target proteins p-p38, p38,
p-JNK and JNK, and the p-p38/p38 and p-JNK/JNK
ratios are given in Table 1. An immunoblot is shown in
Figure 3.
DISCUSSION
In recent years, diabetic cognitive dysfunction has
drawn increasing attention. A series of retrospective
studies have shown that the rate of cognitive decline in
diabetic patients, compared with non-diabetic patients,
is higher, as is the risk of cognitive dysfunction.13 At
present, the mechanisms underlying diabetic cognitive
dysfunction remain unclear. However, it has been
found that diabetes triggers chronic dysfunction of the
central nervous system through oxidative stress,14 in-
flammatory reactions,15 increased levels of advanced
glycation end products,16 endoplasmic reticulum
stress,17 impaired mitochondrial function, and other
processes.18, 19
The MAPK signaling pathway plays an important role
in the regulation of the cell cycle and gene expression.20
p38 MAPK and JNK/MAPK mediate apoptotic signal-
ing after activation, and SB239063 and SP600125 are,
respectively, commonly used inhibitors of these path-
ways. Glucose at high concentration can activate the
MAPK signaling pathway in primary cultured rat dor-
sal root ganglion neurons, diabetic rats, and in sural
nerve specimens from diabetic patients.21
In the present study, high-glucose medium significant-
ly enhanced the apoptosis rate in cultured hippocam-
pal neurons. The p-p38/p38 and p-JNK/JNK ratios
were significantly increased, compared with the control
group. These results suggest that the p38 MAPK and
JNK signaling pathways are activated by high glucose
levels. SB239063 and SP600125 blocked their respec-
tive signaling pathways and prevented the increase in
the apoptosis rate, suggesting that high glucose induces
apoptosis in cultured hippocampal neurons through
the p38 MAPK and JNK signaling pathways. Com-
pared with the high-glucose group, the p-p38/p38 and
p-JNK/JNK ratios were both decreased in the puerarin
group, suggesting that puerarin exerts its anti-apoptotic
effect by reducing the phosphorylation of both p38
and JNK.
Diabetic cognitive dysfunction can be considered a
combination of diabetes with dementia and amnesia ac-
cording to TCM. Shen Nong Ben Cao Jing describes Ge-
gen (Radix Puerariae Lobatae) as an herb widely used
in TCM to promote circulation for stasis dispersion
and to help form saliva for thirst satisfaction.22 The pres-
ent study was undertaken based on this TCM concept.
Puerarin is an isoflavone glycoside extracted from Ge-
gen (Radix Puerariae Lobatae), and has been suggested
to have a number of pharmacological effects, including
cardiovascular protection,23,24 anti-oxidative actions,25
and suppression of apoptosis.26 Current studies have in-
Group
Control
High- glucose
Puerarin
p38MAPK inhibitor
JNK inhibitor
n
3
3
3
3
3
p-p38 (/β-actin)
(×10－2)
6.67±0.21
20.93±0.24a
10.22±0.09bce
1.62±0.37ac
18.40±0.32ade
p38 (/β-actin)
(×10－2)
47.37±0.16
49.44±0.22b
49.96±0.17bf
52.63±0.17ad
50.12±0.25bf
p-p38/p38
14.09±0.39
42.34±0.47a
20.45±0.20aceg
3.07±0.69ac
36.72±0.47ace
p-JNK (/β-actin)
(×10－2)
10.13±0.20
29.68±0.27a
14.98±0.15acg
30.70±0.30adg
2.73±0.11ac
JNK (/β-actin)
(×10－2)
48.88±0.29
47.56±0.04b
47.53±0.10b
52.16±0.10bcg
47.46±0.18b
p-JNK/JNK
20.72±0.33
62.41±0.58a
31.52±0.39aeg
58.85±0.65adg
5.74±0.21ac
Table 1 Levels of p-p38, p38, phosphorylated-c--JNK) and c- JNK and the p-p38/p38 and p-JNK/JNK ratiosin the various groups ( xˉ
± s)
Notes: control group, cells were cultured with DMEM complete medium for 72 h; high-glucose group, cells were cultured with glucose
(50 mmol/L) for 72 h; puerarin group, cells were cultured with puerarin (25 μmol/L) for 72 h; p38 MAPK inhibitor group, cells were cul-
tured with SB239063 (10 μmol/L) for 72 h; JNK inhibitor group, cells were cultured with SP600125 (10 μmol/L) for 72 h. DMEM: dul-
becco's modified eagle medium; MAPK: mitogen activated protein kinase; JNK: c-Jun N-terminal kinase. aP < 0.01, bP < 0.05, compared
with the control group; cP < 0.01, dP < 0.05, compared with the high-glucose group; eP < 0.01, fP < 0.05, compared with the p38 MAPK
inhibitor group; gP < 0.01, compared with the JNK inhibitor group.
Figure 3Western blots for p-p38, p38, p-JNK, JNK and β-actin
C: control group; G: high-glucose group; GG: puerarin
group; i-p38: p38 MAPK inhibitor group; i-JNK: c- JNK inhibi-
tor group. MAPK: mitogen activated protein kinase; JNK:
c-Jun N-terminal kinase.
p-p38
p38
p-JNK
JNK
β-actin
kDa
40
40
46.5
46.5
43
C G GG i-p38 i JNK
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dicated that Puerariae can mitigate damage to PC12
cells and islet cells caused by H2O2,9,27 relieve oxidative
stress in hippocampal neurons induced by Aβ protein,
and alleviate apoptosis in PC12 cells induced by tolu-
ene pyridine by inhibiting the JNK pathway.9, 28-30
In the current study, we showed that puerarin attenu-
ates neuronal apoptosis induced by high glucose by de-
creasing the phosphorylation of p38 and JNK. Further
study is required to clarify how puerarin reduces p38
and JNK phosphorylation.
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